The rapid introduction of novel and diverse psychoactive substances on the designer drug scene continues to pose a challenge. Listen as Dr. Donna Iula, Cayman’s Vice President of Forensic Chemistry, describes the challenges of staying on top of this evolving market and what goes into the production of authentic reference standards. She will also discuss some of the latest NPS developments with a particular emphasis on recent changes within the synthetic cannabinoid landscape.